# A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

> **NCT02567578** · PHASE2 · TERMINATED · sponsor: **Yuhan Corporation** · enrollment: 12 (actual)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** YH12852 0.1 mg
- **DRUG:** YH12852 0.25 mg
- **DRUG:** YH12852 0.5 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02567578
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2017-03-16
- **Final completion:** 2017-03-16
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Technology transfer
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02567578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02567578, "A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02567578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*